|
|
News Breaks
|
October 23, 2009
|
| 07:40 EDT |  | MRX |
| theflyonthewall.com: | Medicis upgraded at Thomas Weisel | | As reported previously, Thomas Weisel upgraded Medicis to Outperform from Market Weight. The firm upgraded shares based on the long-term sustainability of the Soldyn franchise, consumer stabilization, and potential growth drivers from LipoSonix and next generation toxin products. Target to $29 from $21. :theflyonthewall.com |
|
|
News For MRX From The Last 14 Days Check below for free stories on MRX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
January 31, 2012
|
| 11:21 EDT |  | MRX |
|
|
|
|
|
Subscribe for More Information